Acamprosate Calcium Tablets Shortage
Last Updated: September 3, 2025
Status: Current
Products Affected - Description
-
- Acamprosate calcium oral tablet, Glenmark, 333 mg, bottle, 180 count, NDC 68462-0435-18
- Acamprosate calcium oral tablet, Zydus, 333 mg, bottle, 180 count, NDC 68382-0569-28
Reason for the Shortage
-
- Glenmark states the reason for the shortage is regulatory issues.
- Viatris has acamprosate tablets available.
- Zydus did not provide a reason for the shortage.
Available Products
-
- Acamprosate calcium oral tablet, Mylan (Viatris), 333 mg, bottle, 180 count, NDC 00378-6333-80
Estimated Resupply Dates
-
- Glenmark has acamprosate 333 mg tablets on back order and the company estimates a release date of late-September 2025.
- Zydus has acamprosate 333 mg tablets temporarily discontinued.
Updated
Updated September 3, 2025 by Leslie Jensen, PharmD, Drug Information Specialist. Created September 30, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.